Healthcare Sector
Medical Laboratories Industry 
|
|
|
Data by Company within Medical Laboratories Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Alliance Healthcare Services, Inc |
$ 189 |
$ 524 |
$ 18 |
- |
| American Shared Hospital Services |
$ 8 |
$ 20 |
$ 1 |
- |
| Arrowhead Pharmaceuticals, Inc. |
$ 6,853 |
$ 169 |
$ 68 |
- |
| Bioanalytical Systems Inc |
$ 47 |
$ 38 |
$ -1 |
- |
| Biocept Inc |
$ 12 |
$ 5 |
$ -26 |
- |
| Cannlabs, Inc. |
- |
- |
$ 0 |
- |
| Cascadian Therapeutics, Inc. |
$ 508 |
- |
$ -58 |
- |
| Cannabis Science, Inc. |
$ 12 |
$ 0 |
$ -9 |
- |
| Cleveland Biolabs Inc |
$ 7 |
$ 1 |
$ -2 |
- |
| Cryo Cell International Inc |
$ 66 |
$ 32 |
$ 2 |
- |
| Caredx, Inc. |
$ 899 |
$ 115 |
$ -21 |
- |
| Cancer Genetics, Inc |
$ 14 |
$ 17 |
$ -10 |
- |
| China Health Industries Holdings, Inc. |
$ 52 |
$ 9 |
$ 3 |
- |
| Nuo Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Charles River Laboratories International Inc |
$ 7,262 |
$ 2,449 |
$ 221 |
- |
| Wod Retail Solutions, Inc. |
$ 1 |
- |
$ 24 |
- |
| Quest Diagnostics Inc |
$ 14,648 |
$ 7,639 |
$ 780 |
45,000 |
| Dyax Corp |
- |
- |
$ 0 |
- |
| Enzo Biochem Inc |
$ 131 |
$ 81 |
$ 2 |
- |
| Exact Sciences Corporation |
$ 11,174 |
$ 724 |
$ -216 |
- |
| Exelixis, Inc. |
$ 5,476 |
$ 957 |
$ 612 |
- |
| First Choice Healthcare Solutions, Inc. |
$ 6 |
$ 87 |
$ -4 |
- |
| Foundation Medicine, Inc. |
$ 5,041 |
$ 179 |
$ -152 |
- |
| Evolutionary Genomics, Inc. |
$ 8 |
$ 0 |
$ -1 |
- |
| Prolung Inc |
- |
- |
$ -6 |
- |
| Genomic Health, inc |
$ 2,471 |
$ 442 |
$ 57 |
- |
| Complete Genomics Inc |
- |
- |
$ 0 |
- |
| Geovax Labs, Inc. |
$ 0 |
$ 2 |
$ -2 |
- |
| Human Genome Sciences Inc |
- |
- |
$ 0 |
- |
| Icagen, Inc. |
- |
$ 14 |
$ -12 |
- |
| Icon Plc |
$ 8,870 |
$ 3,250 |
$ 499 |
- |
| Imaging3 Inc |
- |
$ 0 |
$ 3 |
- |
| Incyte Corp |
$ 20,577 |
$ 2,108 |
$ 405 |
- |
| International Stem Cell Corp |
$ 4 |
$ 9 |
$ -3 |
- |
| Kraig Biocraft Laboratories, Inc |
$ 166 |
$ 0 |
$ -3 |
5 |
| Laboratory Corp Of America Holdings |
$ 16,840 |
$ 11,389 |
$ 756 |
36,000 |
| Luna Innovations Inc |
$ 242 |
$ 59 |
$ -11 |
- |
| Yield10 Bioscience, Inc. |
- |
$ 1 |
$ -8 |
68 |
| Medical Imaging Corp. |
$ 0 |
$ 7 |
$ -3 |
- |
| Miragen Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Nanoviricides, Inc. |
$ 9 |
- |
$ -8 |
- |
| Natera, Inc. |
$ 2,587 |
$ 286 |
$ -121 |
- |
| Nuo Therapeutics, Inc. |
- |
$ 7 |
$ -51 |
- |
| Invitae Corp |
$ 1,607 |
$ 177 |
$ -148 |
- |
| Nexeon Medsystems Inc |
- |
- |
$ -2 |
- |
| Pressure Biosciences Inc |
$ 1 |
$ 2 |
$ -14 |
- |
| Pacifichealth Laboratories Inc |
- |
- |
$ 0 |
- |
| Pieris Pharmaceuticals, Inc. |
$ 169 |
$ 34 |
$ -36 |
- |
| Psychemedics Corp |
$ 49 |
$ 39 |
$ 3 |
- |
| Pra Health Sciences, Inc. |
$ 7,208 |
$ 2,996 |
$ 239 |
- |
| Parexel International Corp |
$ 4,510 |
$ 2,442 |
$ 107 |
- |
| Prourocare Medical Inc. |
- |
- |
$ 0 |
- |
| Radnet, Inc. |
$ 992 |
$ 1,133 |
$ 50 |
- |
| Response Biomedical Corp |
- |
- |
$ 0 |
- |
| Sunshine Biopharma, Inc |
$ 0 |
$ 0 |
$ -2 |
- |
| Miragen Therapeutics, Inc. |
- |
$ 4 |
$ -42 |
- |
| Senomyx Inc |
$ 72 |
$ 26 |
$ -2 |
- |
| Angiosoma, Inc. |
$ 0 |
- |
$ -1 |
2 |
| Sorrento Therapeutics, Inc. |
$ 466 |
$ 24 |
$ -323 |
- |
| Stallion Synergies, Inc |
- |
- |
$ 0 |
- |
| Dr. Tattoff, Inc. |
- |
- |
$ 0 |
- |
| Tenax Therapeutics, Inc. |
$ 8 |
- |
$ 22 |
- |
| Titanium Healthcare, Inc. |
- |
- |
$ 0 |
- |
| United Health Products, Inc. |
$ 247 |
$ 0 |
$ -5 |
- |
| Veracyte, Inc. |
$ 1,418 |
$ 116 |
$ -8 |
- |
| Vitro Diagnostics Inc, |
- |
- |
$ 0 |
- |
| Intrexon Corporation |
$ 826 |
$ 135 |
$ -502 |
- |
| Celcuity Inc. |
$ 111 |
- |
$ -7 |
- |
| Iqvia Holdings Inc. |
$ 29,550 |
$ 10,791 |
$ 283 |
- |
| National Research Corporation |
$ 1,636 |
$ 126 |
$ 32 |
- |
| Guardant Health, Inc. |
$ 6,903 |
$ 130 |
$ -22 |
- |
| Syneos Health, Inc. |
$ 5,832 |
$ 4,608 |
$ 86 |
- |
| Livongo Health, Inc. |
- |
- |
$ 0 |
- |
| Medical Laboratories Industry |
$ 165,786 |
$ 53,404 |
$ 2,430 |
81,075 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Medical Laboratories Industry in the current quarter, 100 % of companies, who provide earning guidance within Medical Laboratories Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Medical Laboratories Industry. |
Earnings Estimates
decrease
There were no decreases in earnings estimates within Medical Laboratories Industry |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
Within Medical Laboratories Industry there were no increases of sales guidance. |
Sales Expectations unchanged
Among companies who provide sales guidance within Medical Laboratories Industry 50 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
On the negative side, 50 % of businesses within Medical Laboratories Industry, that provide top-line expectation, expect now to sell less, compare to the previous guidance. |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
